SMIM20 and metabolic dysfunction-associated steatotic liver disease: For instance, improving liver lipid metabolism and reducing systemic inflammation, which are critical in managing non-alcoholic fatty liver disease (NAFLD) associated with obesity, can be achieved through PNX-14 mediated pathways [118].